AETHLON MEDICAL INC AEMD Cash Flow

Aethlon medical inc (AEMD)

CashFlow / Quarterly

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11
Cash flows used in operating activities:
NET LOSS
-820	-1,706	-2,067	-1,646	-2,018	-1,402	-1,152	-1,326	-1,219	-1,308	-1,845	-1,693	-1,213	-2,263	-2,136	-1,257	-1,233	-1,251	-1,216	-928	-1,458	-888	-3,704	-7,518	-2,267	-3,349	-303	-	-	-	-	-	-	-	-
Net income (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	313	-1,422	-1,016	-4,497	-574	-453	-2,585
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
10	2	2	5	8	7	8	8	8	9	9	6	5	10	10	-	-	-	-	-	-	-	-	6	9	2	2	2	2	2	2	3	4	4	4
Gain on debt conversion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Stock based compensation
102	326	326	374	344	336	263	373	323	283	280	306	306	1,523	50	50	50	50	50	77	77	89	170	-	-	74	115	194	175	226	169	149	161	224	224
Change in fair value of derivative liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	78	-2,992	609	-	-1,384	326	-687	2,363	-74	-1,029	-491
Loss on debt extinguishment
0	0	-447	0	0	0	0	0	0	0	-376	0	58	0	-616	0	0	0	0	0	-222	-77	-2,453	-	-	-	-22	-	-	-	-	-	-	-	-
Warrant repricing expense
-	-	-	-	-	-	-	-	-	-	-	0	0	0	345	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Gain) on share for warrant exchanges
-	-	-	-	-	-	-	-0	0	-10	-119	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt discount
0	0	30	-	30	30	30	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of right-of-use asset
-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on settlement of notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	24	-	-	-	-
Amortization of debt discount and deferred financing costs
-	-	-	-	-	-	-	30	30	30	154	154	18	18	27	156	134	113	112	142	109	11	9	0	0	1	2	8	3	98	484	895	180	478	1,043
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9	-	9	9	9	-	-	-	-	-	-	-	-	-	-	-	-
Loss on settlement of convertible note termination
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	360
Liquidated damages
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Common stock issued for services
-	-	-	-	-	-	-	0	0	0	33	0	0	0	0	-	-	-	-	0	62	124	38	127	0	242	21	73	46	15	124	13	78	42	207
Par value of shares issued for repurchase of vested restricted stock units
-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Conversion of debt, accrued liabilities and accrued interest to common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	207	1,058	347	660	226	80	420	0	-	-	747	767	245	339	276	1,195
Reclassification of note payable to convertible note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	75	-	-	-	-
Reclassification of warrant derivative liability into equity
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	10,679	-	-	-	-	12	0	6	26	25	16	212	34
Debt discount on notes payable associated with embedded conversion feature and detachable warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	324	210	426	400
Reclassification of accrued interest to convertible notes payable
-	-	-	-	-	-	-	-	-	-	-	0	0	0	85	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of shares under vested restricted stock units
-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reclassification of warrant derivative liability into equity
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,139	210	106	0	-	-	-	-	-	-	-	-
Debt discount on convertible notes payable
-	-	-	-	-	-	-	-	-	-	242	-80	787	0	75	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reclassification of note payable to convertible notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0
Non-cash rent expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	11	156	0	0	538
Changes in operating assets and liabilities:
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	0	-193	193	-199	197	-185	185	-192	178	-242	246	-84	50	-175	220	-208	-591	0	0	400	-216	-183	0	0
Prepaid expenses and other current assets
-73	-37	-58	181	-59	-54	-38	166	-77	53	0	5	-34	42	-30	-128	73	15	20	26	5	-0	-8	25	-29	20	4	29	0	0	-32	-12	-7	33	-15
Interest receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7
Accounts payable and other current liabilities
-369	154	-56	-1	518	-120	-6	115	-25	-0	-193	271	-74	-18	144	87	10	-189	45	-331	-940	-22	186	-1,222	1,301	-291	258	315	139	86	209	191	351	249	127
Due to related parties
9	7	10	13	-29	8	0	25	15	0	-9	-0	0	30	-116	-10	-49	29	29	-664	-78	70	-21	67	-42	28	62	2	14	0	-10	112	0	-39	39
Net cash used in operating activities
-1,256	-1,073	-1,247	-1,397	-1,086	-991	-818	-1,017	-789	-1,028	-1,074	-953	-788	-935	-827	-	-	-	-	-	-	-	-763	-	-	-	-	-521	-661	-595	-320	-740	-65	-495	-540
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-963	-1,440	-798	-	-	-	-	-	-839	-522	-221	-	-	-	-	-	-	-	-
Cash flows from investing activities:
Purchases of property and equipment
28	119	0	0	0	0	0	1	0	0	23	13	0	1	1	0	9	0	0	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	1
Net cash used in investing activities
-28	-119	-0	0	0	0	0	-1	0	0	-23	-13	0	-1	-1	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	-1
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-9	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows provided by (used in) financing activities:
Proceeds from collection of secured notes receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	200
Proceeds from the issuance of common stock, net, value
4,564	386	36	-	883	0	0	-	-	-	1	-	-	-	-	-	14	0	5,591	0	4,092	349	320	2	2,947	100	128	538	498	271	802	300	0	0	0
Principal payments on convertible notes
0	892	100	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units
6	8	23	-	50	53	32	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for repurchase of restricted stock units
-	-	-	-	-	-	-	-	-	-	136	306	4	67	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Principal repayments of notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	29	208	10	5	0
Proceeds from the issuance of convertible notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	437	384	532	340
Net proceeds from the issuance of common stock and exercise of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net provided by financing activities
4,557	-514	-87	400	832	-53	-32	2,382	5,480	1,621	-134	1,898	860	199	0	-	-	-	-	-	-	-	320	-	-	-	-	538	498	271	772	529	374	527	540
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14	0	5,591	-	-	-	-	-	2,747	500	128	-	-	-	-	-	-	-	-
Net decrease in cash
-	-1,706	-1,335	-	-	-1,044	-851	1,363	4,690	592	-1,232	931	72	-737	-829	-1,127	-958	-1,440	4,793	-	-	-281	-442	-604	1,846	-22	-93	17	-163	-324	452	-210	309	32	-2
Supplement disclosures of cash flow information:
Interest
0	11	71	0	0	95	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	13	-2	2	0	2	-2	2	26	3	0	0
Income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-	-	-	-
Supplemental information of non-cash investing and financing activities:
Initial recognition of right-of-use lease asset and lease liability
0	0	228	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-